Citation Tools

Original research
CBLB ablation with CRISPR/Cas9 enhances cytotoxicity of human placental stem cell-derived NK cells for cancer immunotherapy

Download to a citation manager

Cite this article as:
Guo X, Mahlakõiv T, Ye Q, et al
CBLB ablation with CRISPR/Cas9 enhances cytotoxicity of human placental stem cell-derived NK cells for cancer immunotherapy